Epidemiological study of multiple system atrophy: data from HoRC-MSA Project 2014-2019
Objective: To investigate epidemiological aspects of multiple system atrophy (MSA) in Hokkaido, Japan from the data of the Hokkaido Rare-disease Consortium for MSA (HoRC-MSA). Background:…Profile and progression of cognitive deficits in Progressive Supranuclear Palsy, Multiple System Atrophy and Parkinson’s Disease
Objective: This study investigated neuropsychological tests most sensitive in differentiating progressive supranuclear palsy (PSP) from Parkinson’s disease (PD) and multiple system atrophy (MSA), and in…Quantitative evaluation of gait ataxia of Multiple System Atrophy patients
Objective: To perform gait analysis on patients with multiple system atrophy (MSA) and assess whether the obtained data could be used as neurophysiological biomarkers. Background:…Measuring disease progression with neuroimaging in MSA-a systematic review
Objective: To assess longitudinal changes of serial neuroimaging-derived parameters in MSA. Background: Different neuroimaging modalities hold potential as surrogate markers of neurodegeneration in multiple system…The severity of motor dysfunctions and autonomic dysfunctions are not correlated in multiple system atrophy
Objective: Although it is well known that patients with multiple system atrophy (MSA) cerebellar dominant type (MSA-C) show severe autonomic dysfunction, the relationship between autonomic…Multiple System Atrophy – perspectives in diagnosis?
Objective: The aim of this study was to study the role of perfusion single photon emission computed tomography (SPECT) in the examination of multiple system…Three-year follow-up of a patient with a rare combination of taupathy (PSP) and synucleopathy (MSA)
Objective: We couldn't find an article showing that MSA and PSP appeared simultaneously in the same patient in the english literature. We wanted to present…To compare early / late onset MSA from the PAN American MSA (PANMSA) database
Objective: Compare two different cohorts of patients with the same pathology differentiated by age of onset. Background: Multiple system atrophy (MSA) is a rare neurodegenerative…Multiple System Atrophy: phenotypic spectrum approach coupled with brain FDG PET
Objective: This study attempts to identify different phenotypes of patients with MSA and to describe corresponding brain 18-FDG Positron Emission Tomography (PET) patterns. Background: In…Availability of levodopa and clinicopathological features of patients with multiple system atrophy
Objective: To investigate the availability of levodopa for pathologically confirmed multiple system atrophy (MSA) patients and determine the clinicopathological features of levodopa responders with MSA.…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 20
- Next Page »